Our Pricing

Is Mounjaro Going Down in Price? Understanding UK Cost Trends

Published: 11 September 2026

Is Mounjaro going down in price in the UK? Many patients seeking tirzepatide weight loss treatment are asking this question as demand increases and supply stabilises. While Mounjaro pricing has seen fluctuations since its UK launch, Cured Pharmacy currently offers Mounjaro from £124.99, with £20 off your first order using code Weightlossnew—representing competitive pricing compared to many UK providers.

Is Mounjaro Going Down in Price Across UK Pharmacies?

Is Mounjaro going down in price compared to 2024 levels? The tirzepatide market has experienced pricing adjustments as supply chains stabilise and more UK pharmacies gain access to stock. At Cured Pharmacy, we've maintained transparent pricing at £124.99 per pen, ensuring patients receive genuine UK-licensed Mounjaro without hidden consultation fees or inflated charges[1].

Market pricing for Mounjaro varies significantly across UK providers, with some charging substantially more due to consultation structures or supply constraints. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures that every Mounjaro prescription undergoes proper clinical assessment whilst keeping costs accessible. Patients completing our free online consultation receive upfront pricing before any commitment, with delivery included in the stated price.

The question of whether Mounjaro is going down in price depends partly on dosage requirements. SURPASS clinical trials demonstrated that tirzepatide doses ranging from 5mg to 15mg produced average weight reductions of 15-22.5% over 72 weeks[2]. Your prescriber will determine the appropriate starting dose based on your medical history, with most patients beginning at 2.5mg before titrating upward—meaning your monthly cost may vary as treatment progresses.

Why Is Mounjaro Going Down in Price for Some UK Patients?

Is Mounjaro going down in price due to increased competition? The UK weight loss injection market now includes multiple GLP-1 and dual GIP/GLP-1 receptor agonists, creating competitive pressure that benefits patients. Cured Pharmacy's pricing strategy focuses on volume efficiency and streamlined online consultations, allowing us to offer Mounjaro at £124.99—often lower than high-street pharmacy equivalents.

Supply availability has improved markedly since Mounjaro's initial UK launch, when allocation shortages drove prices upward at some providers. As Eli Lilly expands manufacturing capacity and distribution networks stabilise, registered pharmacies can now secure more consistent stock. This improved supply chain directly contributes to more stable and competitive pricing across the market[3].

Regulatory Factors Affecting Mounjaro Pricing

The MHRA's licensing of tirzepatide for weight management in the UK established quality standards that all providers must meet, but does not regulate retail pricing. Unlike NHS prescription medications with fixed tariffs, private weight loss treatments like Mounjaro operate in a competitive market where pharmacies set their own prices. Cured Pharmacy (GPhC 9012511) maintains full regulatory compliance whilst optimising operational efficiency to keep costs down for patients.

How Does Mounjaro's Price Compare to Alternative Weight Loss Treatments?

When asking is Mounjaro going down in price, patients should also consider value relative to alternative treatments. Wegovy (semaglutide) injections start from £124.99 at Cured Pharmacy, whilst oral semaglutide tablets begin at £124.99. Clinical trial data shows tirzepatide typically produces greater average weight loss than semaglutide—SURMOUNT-1 demonstrated 20.9% average weight reduction with 15mg tirzepatide versus approximately 15% with 2.4mg semaglutide in STEP trials[1][4].

Saxenda (liraglutide), available from £124.99, requires daily injections compared to Mounjaro's weekly dosing. Orlistat capsules, priced from £124.99, work through a completely different mechanism—blocking fat absorption rather than regulating appetite hormones—and typically produce more modest weight loss of 5-10% on average. Your prescriber will recommend the most suitable option based on your medical history, weight loss goals, and budget considerations.

Long-Term Cost Considerations for Tirzepatide Treatment

Is Mounjaro going down in price over the course of treatment? Most patients require 6-12 months of tirzepatide therapy to achieve optimal results, with some continuing maintenance dosing longer term. At £124.99 per pen, monthly costs depend on your prescribed dose—maintenance doses of 10mg or 15mg may require multiple pens monthly. Cured Pharmacy offers ongoing support through our clinical team, ensuring dose adjustments occur only when medically appropriate rather than to increase sales.

Where to Find the Best Mounjaro Prices in the UK

Is Mounjaro going down in price at your current provider? Comparing registered UK pharmacies reveals significant price variation, with some charging £124.99 or more per pen. Cured Pharmacy's £124.99 pricing includes free online consultation with a UK prescriber, discreet home delivery, and ongoing clinical support—no hidden fees or subscription traps[5].

Beware of unusually low prices that may indicate unregulated sources or counterfeit medications. All legitimate Mounjaro in the UK must be UK-licensed tirzepatide supplied by GPhC-registered pharmacies following proper prescription protocols. Our superintendent pharmacist verifies every medication batch, ensuring you receive genuine Eli Lilly Mounjaro KwikPens with full UK regulatory approval.

Is Mounjaro Going Down in Price Due to New Dosage Options?

Is Mounjaro going down in price as new formulations enter the market? Currently, Mounjaro is available exclusively as pre-filled KwikPen injections in doses from 2.5mg to 15mg. Unlike semaglutide, which now has oral tablet options (Wegovy® Oral Tablets from £124.99), tirzepatide remains injection-only in the UK. Future formulations could affect pricing dynamics, though no oral tirzepatide has yet received MHRA approval.

The dose-escalation protocol for Mounjaro means most patients start at 2.5mg for four weeks, then increase to 5mg, with further increases to 7.5mg, 10mg, or 15mg based on response and tolerability[2]. This graduated approach optimises gastrointestinal tolerability whilst building efficacy. Your prescriber will adjust dosing during follow-up consultations, which Cured Pharmacy provides at no additional charge as part of ongoing care.

Maximising Value from Your Mounjaro Prescription

Is Mounjaro going down in price when combined with lifestyle modifications? While medication cost remains fixed, patients who engage actively with dietary changes and increased physical activity often achieve target weight loss more quickly, potentially reducing total treatment duration. Clinical trials showed that tirzepatide works synergistically with caloric restriction and exercise, with participants in structured programmes experiencing enhanced outcomes[6]. Cured Pharmacy provides educational resources to support your weight management journey alongside medication.

Future Mounjaro Pricing Trends in the UK Market

Is Mounjaro going down in price in 2025 and beyond? Market analysts predict continued stabilisation as supply constraints ease and competition intensifies. Potential biosimilar tirzepatide products may eventually enter the UK market, though GLP-1 receptor agonist patents typically protect innovator medications for extended periods. Cured Pharmacy commits to maintaining competitive pricing whilst never compromising on medication authenticity or clinical safety standards.

NHS availability of Mounjaro for obesity treatment remains limited to specific criteria, meaning most UK patients access tirzepatide through private prescriptions. NICE guidance currently restricts NHS tirzepatide to type 2 diabetes management in certain circumstances, with weight management indications assessed case-by-case[7]. Private pricing at pharmacies like Cured therefore represents the primary access route for weight loss patients, making transparent and competitive pricing essential.

Patients can optimise costs by using discount codes—Cured Pharmacy offers £20 off first orders with code Weightlossnew—and by ensuring proper dose titration under prescriber guidance. Avoid overpaying by confirming your pharmacy is GPhC-registered, provides clear upfront pricing, and supplies genuine UK-licensed medications. Our team at (+44) 116 4646009 can answer specific pricing questions before you commit to treatment.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Garvey, W. T. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 11 September 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Tirzepatide (Mounjaro): supply and availability update. GOV.UK. [accessed 11 September 2026]
4. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & STEP 1 Study Group. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 11 September 2026]
5. General Pharmaceutical Council. (2024). Registered pharmacy premises. GPhC Register. [accessed 11 September 2026]
6. Wadden, T. A., Bailey, T. S., Billings, L. K., Davies, M., Frias, J. P., Koroleva, A., ... & STEP 3 Investigators. (2021). Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity. JAMA, 325(14), 1403-1413. [accessed 11 September 2026]
7. National Institute for Health and Care Excellence. (2024). Tirzepatide for treating type 2 diabetes. NICE Technology Appraisal Guidance. [accessed 11 September 2026]
8. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
9. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
10. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.